Video Ad Feedback
FDA approves first postpartum depression drug
For the first time in history, the US Food and Drug Administration has approved a drug specifically indicated for the treatment of postpartum depression, which experts say offers new hope to women and physicians. The FDA announced the approval of an intravenous infusion of the drug brexanolone, which will be sold as Zulresso. It has been shown in clinical trials to work within hours to treat the symptoms of postpartum depression, a serious mental illness that impacts 1 in 9 new mothers after childbirth. CNN's Dr. Sanjay Gupta reports.
02:00
- Source:
CNN
Latest Videos
16 videos
Video Ad Feedback
Utah women's basketball coach describes 'racial hate' she says the team experienced
Video Ad Feedback
RFK Jr. supporters were asked who they'd vote for if he was not running. Hear their responses
Video Ad Feedback
Planned Parenthood CEO on how Supreme Court justices reacted to abortion pill hearing
Video Ad Feedback
Video shows what happened right before ship hit bridge
Video Ad Feedback
'Shocking sight to see:' Witness reacts to bridge collapse
Video Ad Feedback
Trump snaps at reporter over campaign funding question. Here are the facts
Video Ad Feedback
What we know about the raids on Sean 'Diddy' Combs' homes
Video Ad Feedback
Why an ex-NBC host supports the network's controversial hiring of Ronna McDaniel
Video Ad Feedback
'Why is our tail on fire': Passenger records carnival cruise ship on fire
Video Ad Feedback
Why mayor of this major US city is suing the ATF to get gun data
Video Ad Feedback
Lawmakers were in a standoff before reaching funding deal. Here's why
Video Ad Feedback
Shohei Ohtani connected to MLB gambling allegations probe